Jarislowsky, Fraser Ltd’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15.5M | Sell |
20,327
-220
| -1% | -$164K | 0.09% | 80 |
|
|
2025
Q2 | $16M | Sell |
20,547
-1,375
| -6% | -$1.07M | 0.09% | 81 |
|
|
2025
Q1 | $18.1M | Sell |
21,922
-840
| -4% | -$699K | 0.11% | 80 |
|
|
2024
Q4 | $17.6M | Sell |
22,762
-987
| -4% | -$817K | 0.1% | 80 |
|
|
2024
Q3 | $21M | Sell |
23,749
-2,023
| -8% | -$1.82M | 0.12% | 78 |
|
|
2024
Q2 | $23.3M | Sell |
25,772
-5,895
| -19% | -$4.72M | 0.14% | 74 |
|
|
2024
Q1 | $24.6M | Sell |
31,667
-7,003
| -18% | -$4.98M | 0.14% | 76 |
|
|
2023
Q4 | $22.5M | Sell |
38,670
-728
| -2% | -$425K | 0.13% | 75 |
|
|
2023
Q3 | $21.2M | Sell |
39,398
-2,298
| -6% | -$1.18M | 0.14% | 75 |
|
|
2023
Q2 | $19.6M | Sell |
41,696
-17,767
| -30% | -$7.45M | 0.12% | 78 |
|
|
2023
Q1 | $20.4M | Sell |
59,463
-1,494
| -2% | -$504K | 0.13% | 74 |
|
|
2022
Q4 | $22.3M | Hold |
60,957
| – | – | 0.15% | 75 |
|
|
2022
Q3 | $19.7M | Sell |
60,957
-259
| -0.4% | -$82.1K | 0.14% | 76 |
|
|
2022
Q2 | $19.8M | Sell |
61,216
-747
| -1% | -$224K | 0.13% | 78 |
|
|
2022
Q1 | $17.7M | Sell |
61,963
-1,000
| -2% | -$257K | 0.09% | 84 |
|
|
2021
Q4 | $17.4M | Sell |
62,963
-9,403
| -13% | -$2.38M | 0.08% | 85 |
|
|
2021
Q3 | $16.7M | Sell |
72,366
-1,525
| -2% | -$376K | 0.08% | 84 |
|
|
2021
Q2 | $17M | Sell |
73,891
-16,130
| -18% | -$3.24M | 0.08% | 85 |
|
|
2021
Q1 | $16.8M | Sell |
90,021
-4,925
| -5% | -$963K | 0.08% | 79 |
|
|
2020
Q4 | $16M | Sell |
94,946
-800
| -0.8% | -$119K | 0.08% | 78 |
|
|
2020
Q3 | $14.2M | Sell |
95,746
-75
| -0.1% | -$11.6K | 0.08% | 80 |
|
|
2020
Q2 | $15.7M | Sell |
95,821
-1,060
| -1% | -$163K | 0.1% | 79 |
|
|
2020
Q1 | $13.4M | Sell |
96,881
-2,675
| -3% | -$368K | 0.1% | 79 |
|
|
2019
Q4 | $13.1M | Hold |
99,556
| – | – | 0.07% | 88 |
|
|
2019
Q3 | $11.1M | Sell |
99,556
-100
| -0.1% | -$11.1K | 0.06% | 91 |
|
|
2019
Q2 | $11M | Sell |
99,656
-3,050
| -3% | -$359K | 0.07% | 89 |
|
|
2019
Q1 | $13.3M | Buy |
102,706
+860
| +0.8% | +$105K | 0.08% | 89 |
|
|
2018
Q4 | $11.8M | Hold |
101,846
| – | – | 0.08% | 90 |
|
|
2018
Q3 | $11M | Sell |
101,846
-150
| -0.1% | -$15K | 0.07% | 99 |
|
|
2018
Q2 | $8.7M | Sell |
101,996
-1,035
| -1% | -$85K | 0.05% | 103 |
|
|
2018
Q1 | $7.97M | Sell |
103,031
-31
| -0% | -$2.5K | 0.05% | 105 |
|
|
2017
Q4 | $8.7M | Sell |
103,062
-265
| -0.3% | -$22.5K | 0.05% | 107 |
|
|
2017
Q3 | $8.84M | Hold |
103,327
| – | – | 0.05% | 111 |
|
|
2017
Q2 | $8.5M | Buy |
103,327
+31
| +0% | +$2.53K | 0.05% | 110 |
|
|
2017
Q1 | $8.69M | Sell |
103,296
-177
| -0.2% | -$14.2K | 0.06% | 111 |
|
|
2016
Q4 | $7.61M | Buy |
+103,473
| New | +$7.71M | 0.05% | 116 |
|
Other funds holding LLY
Jarislowsky, Fraser Ltd's LLY Position: Q3 2025 in Review
Jarislowsky, Fraser Ltd reduced its Eli Lilly (LLY) stake by 1.1% in Q3 2025, selling an estimated $164K and leaving 20,327 shares worth $15.5M. The position accounts for 0.09% of the portfolio, ranked #80.
Jarislowsky, Fraser Ltd first reported a position in LLY in Q4 2016 and has held it in 36 quarters since. The position peaked at $24.6M in Q1 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.
- Jarislowsky, Fraser Ltd held 20,327 shares of Eli Lilly worth $15.5M as of Q3 2025.
- Jarislowsky, Fraser Ltd sold 220 Eli Lilly shares in Q3 2025, an estimated $164K.
- Eli Lilly made up 0.09% of Jarislowsky, Fraser Ltd's portfolio in Q3 2025, its #80 holding.
- Jarislowsky, Fraser Ltd first reported a position in Eli Lilly in Q4 2016 and has held it in 36 quarters since.
- Jarislowsky, Fraser Ltd's Eli Lilly position peaked at $24.6M in Q1 2024.
- 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.
Based on Jarislowsky, Fraser Ltd's 13F filing for Q3 2025, filed 21 Oct 2025.